vti_encoding:SR|utf8-nl
vti_author:SR|IMANDT\\mhowarth
vti_modifiedby:SR|IMANDT\\mhowarth
vti_timelastmodified:TR|20 Jan 2017 09:16:38 -0000
vti_timecreated:TR|20 Jan 2017 09:12:01 -0000
vti_title:SR|ABACAVIR | Drug | BNF Provided by NICE
vti_extenderversion:SR|12.0.0.0
vti_backlinkinfo:VX|NICE_BNF_Drugs_Monograph_v1.html
vti_nexttolasttimemodified:TW|20 Jan 2017 09:12:01 -0000
vti_cacheddtm:TX|20 Jan 2017 09:16:38 -0000
vti_filesize:IR|30585
vti_cachedtitle:SR|ABACAVIR | Drug | BNF Provided by NICE
vti_cachedbodystyle:SR|<body id="abacavir" class="drug" data-publication="bnf" data-buildnumber="1.0.706" data-release="beta">
vti_cachedlinkinfo:VX|H|http://test-bnf.nice.org.uk/drug/abacavir.json H|http://test-bnf.nice.org.uk/drug/abacavir.ttl X|https://cdn.nice.org.uk/V3http://test-bnf.nice.org.uk/scripts/html5shiv/html5shiv.js Q|http://fonts.googleapis.com/css H|https://www.nice.org.uk/Media/Default/css/bootstrapV3.1/NICE.bootstrap.css Q|http://maxcdn.bootstrapcdn.com/font-awesome/4.5.0/css/font-awesome.min.css X|https://cdn.nice.org.uk/V3/Content/NICE.glyphs-ie7.css H|https://cdn.nice.org.uk/V3/Content/nice/favicon.ico H|https://cdn.nice.org.uk/V3/Content/nice/favicon-152.png Q|http://test-bnf.nice.org.uk/styles/header.css Q|http://test-bnf.nice.org.uk/styles/footer.css Q|http://test-bnf.nice.org.uk/styles/style.css Q|http://test-bnf.nice.org.uk/styles/bnf.css S|//www.googletagmanager.com/ns.html H|/drug H|/interaction H|/treatment-summary H|/about/changes.html H|https://insights.hotjar.com/s H|../ H|./ H|/ K|NICE_BNF_Drugs_Monograph_v1.html K|NICE_BNF_Drugs_Monograph_v1.html K|NICE_BNF_Drugs_Monograph_v1.html K|NICE_BNF_Drugs_Monograph_v1.html K|NICE_BNF_Drugs_Monograph_v1.html K|NICE_BNF_Drugs_Monograph_v1.html K|NICE_BNF_Drugs_Monograph_v1.html K|NICE_BNF_Drugs_Monograph_v1.html K|NICE_BNF_Drugs_Monograph_v1.html K|NICE_BNF_Drugs_Monograph_v1.html K|NICE_BNF_Drugs_Monograph_v1.html K|NICE_BNF_Drugs_Monograph_v1.html K|NICE_BNF_Drugs_Monograph_v1.html H|/interaction/abacavir-2.html K|/drug-class/nucleoside-reverse-transcriptase-inhibitors.html K|/drug-class/nucleoside-reverse-transcriptase-inhibitors.html K|/drug-class/nucleoside-reverse-transcriptase-inhibitors.html H|../medicinal-forms/abacavir.html H|../treatment-summary/hiv-infection.html H|/drug-classification/primary/abacavir.html H|/ H|//www.nice.org.uk/about H|//www.nice.org.uk/about/what-we-do/into-practice H|//www.nice.org.uk/news H|//www.nice.org.uk/get-involved/contact-us H|//www.nice.org.uk/leave-feedback H|//www.nice.org.uk/get-involved/jobs H|http://www.nice.org.uk/news/nice-newsletters-and-alerts H|//twitter.com/NICEcomms H|//www.youtube.com/user/NICEmedia H|//www.linkedin.com/company/national-institute-for-health-and-clinical-excellence H|//www.nice.org.uk/guidance H|//pathways.nice.org.uk H|//www.nice.org.uk/standards-and-indicators H|//www.nice.org.uk/savingsandproductivity/collection H|//www.evidence.nhs.uk/ H|//www.evidence.nhs.uk/formulary/bnf/current H|//www.evidence.nhs.uk/formulary/bnfc/current H|//cks.nice.org.uk H|//www.nice.org.uk/about/what-we-do/evidence-services/journals-and-databases H|//www.nice.org.uk/about/what-we-do/nice-syndication-api H|//play.google.com/store/apps/details H|//itunes.apple.com/gb/app/nice-guidance/id505146575 H|/about/ H|https://insights.hotjar.com/s H|//www.nice.org.uk/accessibility H|//www.nice.org.uk/freedom-of-information H|//www.nice.org.uk/re-using-our-content H|//www.nice.org.uk/glossary H|//www.nice.org.uk/terms-and-conditions S|https://www.nice.org.uk/Media/Default/js/NICE.TopHat.dev.js S|https://cdn.nice.org.uk/V3http://test-bnf.nice.org.uk/scripts/jquery/jquery-1.10.2.min.js S|https://cdn.nice.org.uk/V3http://test-bnf.nice.org.uk/scripts/twitter.bootstrap.min.js S|https://cdn.nice.org.uk/V3http://test-bnf.nice.org.uk/scripts/NICE.bootstrap.min.js S|https://cdn.nice.org.uk/V3http://test-bnf.nice.org.uk/scripts/nice/NICE.EventTracking.js S|http://test-bnf.nice.org.uk/scripts/remoteload.js S|http://test-bnf.nice.org.uk/scripts/NICE.scrollspy.js S|http://test-bnf.nice.org.uk/scripts/NICE.asyoutype.js S|http://test-bnf.nice.org.uk/scripts/NICE.bnf.js
vti_cachedsvcrellinks:VX|NHHS|http://test-bnf.nice.org.uk/drug/abacavir.json NHHS|http://test-bnf.nice.org.uk/drug/abacavir.ttl NXSS|https://cdn.nice.org.uk/V3http://test-bnf.nice.org.uk/scripts/html5shiv/html5shiv.js NQHS|http://fonts.googleapis.com/css NHSS|https://www.nice.org.uk/Media/Default/css/bootstrapV3.1/NICE.bootstrap.css NQHS|http://maxcdn.bootstrapcdn.com/font-awesome/4.5.0/css/font-awesome.min.css NXSS|https://cdn.nice.org.uk/V3/Content/NICE.glyphs-ie7.css NHSS|https://cdn.nice.org.uk/V3/Content/nice/favicon.ico NHSS|https://cdn.nice.org.uk/V3/Content/nice/favicon-152.png NQHS|http://test-bnf.nice.org.uk/styles/header.css NQHS|http://test-bnf.nice.org.uk/styles/footer.css NQHS|http://test-bnf.nice.org.uk/styles/style.css NQHS|http://test-bnf.nice.org.uk/styles/bnf.css NSUS|//www.googletagmanager.com/ns.html NHUS|/drug NHUS|/interaction NHUS|/treatment-summary NHUS|/about/changes.html NHSS|https://insights.hotjar.com/s NHUS|file:///C:/Users/mhowarth/Documents/GitHub/NICE.Design/ WHUS|default.html NHUS|file:/// FKUS|NICE_BNF_Drugs_Monograph_v1.html FKUS|NICE_BNF_Drugs_Monograph_v1.html FKUS|NICE_BNF_Drugs_Monograph_v1.html FKUS|NICE_BNF_Drugs_Monograph_v1.html FKUS|NICE_BNF_Drugs_Monograph_v1.html FKUS|NICE_BNF_Drugs_Monograph_v1.html FKUS|NICE_BNF_Drugs_Monograph_v1.html FKUS|NICE_BNF_Drugs_Monograph_v1.html FKUS|NICE_BNF_Drugs_Monograph_v1.html FKUS|NICE_BNF_Drugs_Monograph_v1.html FKUS|NICE_BNF_Drugs_Monograph_v1.html FKUS|NICE_BNF_Drugs_Monograph_v1.html FKUS|NICE_BNF_Drugs_Monograph_v1.html NHUS|/interaction/abacavir-2.html NHUS|/drug-class/nucleoside-reverse-transcriptase-inhibitors.html NHUS|/drug-class/nucleoside-reverse-transcriptase-inhibitors.html NHUS|/drug-class/nucleoside-reverse-transcriptase-inhibitors.html NHUS|file:///C:/Users/mhowarth/Documents/GitHub/NICE.Design/medicinal-forms/abacavir.html NHUS|file:///C:/Users/mhowarth/Documents/GitHub/NICE.Design/treatment-summary/hiv-infection.html NHUS|/drug-classification/primary/abacavir.html NHUS|file:/// NHUS|//www.nice.org.uk/about NHUS|//www.nice.org.uk/about/what-we-do/into-practice NHUS|//www.nice.org.uk/news NHUS|//www.nice.org.uk/get-involved/contact-us NHUS|//www.nice.org.uk/leave-feedback NHUS|//www.nice.org.uk/get-involved/jobs NHHS|http://www.nice.org.uk/news/nice-newsletters-and-alerts NHUS|//twitter.com/NICEcomms NHUS|//www.youtube.com/user/NICEmedia NHUS|//www.linkedin.com/company/national-institute-for-health-and-clinical-excellence NHUS|//www.nice.org.uk/guidance NHUS|//pathways.nice.org.uk NHUS|//www.nice.org.uk/standards-and-indicators NHUS|//www.nice.org.uk/savingsandproductivity/collection NHUS|//www.evidence.nhs.uk/ NHUS|//www.evidence.nhs.uk/formulary/bnf/current NHUS|//www.evidence.nhs.uk/formulary/bnfc/current NHUS|//cks.nice.org.uk NHUS|//www.nice.org.uk/about/what-we-do/evidence-services/journals-and-databases NHUS|//www.nice.org.uk/about/what-we-do/nice-syndication-api NHUS|//play.google.com/store/apps/details NHUS|//itunes.apple.com/gb/app/nice-guidance/id505146575 NHUS|/about/ NHSS|https://insights.hotjar.com/s NHUS|//www.nice.org.uk/accessibility NHUS|//www.nice.org.uk/freedom-of-information NHUS|//www.nice.org.uk/re-using-our-content NHUS|//www.nice.org.uk/glossary NHUS|//www.nice.org.uk/terms-and-conditions NSSS|https://www.nice.org.uk/Media/Default/js/NICE.TopHat.dev.js NSSS|https://cdn.nice.org.uk/V3http://test-bnf.nice.org.uk/scripts/jquery/jquery-1.10.2.min.js NSSS|https://cdn.nice.org.uk/V3http://test-bnf.nice.org.uk/scripts/twitter.bootstrap.min.js NSSS|https://cdn.nice.org.uk/V3http://test-bnf.nice.org.uk/scripts/NICE.bootstrap.min.js NSSS|https://cdn.nice.org.uk/V3http://test-bnf.nice.org.uk/scripts/nice/NICE.EventTracking.js NSHS|http://test-bnf.nice.org.uk/scripts/remoteload.js NSHS|http://test-bnf.nice.org.uk/scripts/NICE.scrollspy.js NSHS|http://test-bnf.nice.org.uk/scripts/NICE.asyoutype.js NSHS|http://test-bnf.nice.org.uk/scripts/NICE.bnf.js
vti_cachedneedsrewrite:BR|false
vti_cachedhasbots:BR|false
vti_cachedhastheme:BR|false
vti_cachedhasborder:BR|false
vti_metatags:VR|X-UA-Compatible IE=edge,chrome=1 viewport width=device-width,\\ initial-scale=1,\\ maximum-scale=1 DC.Publisher NICE DC.Rights.Copyright All\\ content\\ on\\ this\\ site\\ is\\ NICE\\ copyright\\ unless\\ otherwise\\ stated.\\ You\\ can\\ download\\ material\\ for\\ private\\ research,\\ study\\ or\\ in-house\\ use\\ only.\\ Do\\ not\\ distribute\\ or\\ publish\\ any\\ material\\ from\\ this\\ site\\ without\\ first\\ obtaining\\ NICE's\\ permission.\\ Where\\ Crown\\ copyright\\ applies,\\ see\\ the\\ Office\\ of\\ Public\\ Sector\\ Information\\ (formerly\\ HMSO)\\ website\\ for\\ information. DC.Language eng DC.Subject Health,\\ well-being\\ and\\ care eGMS.accessibility Double-A DC.Issued 2014-08-05 DC.Modified 2014-08-05 DC.Type CorporatePage DC.Title BNF:\\ British\\ National\\ Formulary\\ -\\ NICE description Indications,\\ dose,\\ contra-indications,\\ side-effects,\\ interactions,\\ cautions,\\ warnings\\ and\\ other\\ safety\\ information\\ for\\ abacavir. author NICE\\ -\\ The\\ National\\ Institute\\ for\\ Health\\ and\\ Care\\ Excellence msapplication-TileColor #f6f6f6 msapplication-TileImage https://cdn.nice.org.uk/V3/Content/nice/favicon-144.png
vti_charset:SR|utf-8
